SCHEMBL20966315

SCHEMBL20966315

CCn1c2ccccc2c2cc(NC(=O)c3nccnc3C(=O)NCCCn3ccnc3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.53
▸ NPY5R Q15761 3/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MAPT P10636 8/20 0.49
▸ MEN1 O00255 7/20 0.49
▸ KMT2A Q03164 7/20 0.49
▸ KDM4E B2RXH2 5/20 0.49
▸ POLB P06746 2/20 0.49
▸ RECQL P46063 1/20 0.49
▸ LMNA P02545 4/20 0.48
▸ HTT P42858 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ HCRTR1 O43613 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ PAX8 Q06710 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29920894 0.83 NPY5R (0.66) HIF1ANPY5RNPSR1MAPTMEN1
SCHEMBL20966314 0.83 NPY5R (0.66) HIF1ANPY5RNPSR1MAPTMEN1
SCHEMBL20966318 0.83 HIF1A (0.59) HIF1ANPY5RNPSR1MAPTMEN1
SCHEMBL20945458 0.82 HSD17B10 (0.51) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL20945436 0.80 HIF1A (0.66) HIF1ANPY5RNPSR1MAPTMEN1
SCHEMBL29920521 0.79 NPY5R (0.68) HIF1ANPY5RNPSR1MAPTMEN1
SCHEMBL20966399 0.79 NPY5R (0.68) HIF1ANPY5RNPSR1MAPTMEN1
SCHEMBL30523145 0.74 KMT2A (0.60) NPY5RNPSR1MAPTMEN1KMT2A
SCHEMBL29059420 0.74 KMT2A (0.60) NPY5RNPSR1MAPTMEN1KMT2A
SCHEMBL20966317 0.73 RAC1 (0.71) NPY5RNPSR1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIV PUERTO RICO (US) 2020-11-12 — — US disclosed
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2020-08-04 — — US disclosed
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIVERSITY OF PUERTO RICO (PR) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, ARHGDIB HIF1A 3566/4885NPY5R 4036/4885NPSR1 4687/4885
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS HIF1A 3643/4885NPY5R 4104/4885NPSR1 4695/4885
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, HRAS HIF1A 3783/4885NPY5R 4274/4885NPSR1 4742/4885
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents CDC42, ARHGEF2, GDI2 HIF1A 3561/4885NPY5R 4077/4885NPSR1 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback